Madison Square Garden Sports Corp is owns and operates a portfolio of assets featuring some of the recognized teams in all of sports, including the Knicks of the National Basketball Association (NBA) and the Rangers of the National Hockey League (NHL)... Show more
a company which engages in the provision sports and entertainment business
Industry MoviesEntertainment
A.I.dvisor indicates that over the last year, MSGS has been loosely correlated with MSGE. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if MSGS jumps, then MSGE could also see price increases.
| Ticker / NAME | Correlation To MSGS | 1D Price Change % | ||
|---|---|---|---|---|
| MSGS | 100% | -1.49% | ||
| MSGE - MSGS | 50% Loosely correlated | -0.07% | ||
| SPHR - MSGS | 34% Loosely correlated | -4.38% | ||
| PSKY - MSGS | 34% Loosely correlated | -9.58% | ||
| MANU - MSGS | 32% Poorly correlated | -1.58% | ||
| TKO - MSGS | 31% Poorly correlated | -2.05% | ||
More | ||||
MSGS moved above its 50-day moving average on September 24, 2026 date and that indicates a change from a downward trend to an upward trend. In 25 of 32 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 78%.
The Momentum Indicator moved above the 0 level on September 24, 2026. You may want to consider a long position or call options on MSGS as a result. In 52 of 83 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 63%.
The Moving Average Convergence Divergence (MACD) for MSGS just turned positive on September 15, 2026. Looking at past instances where MSGS's MACD turned positive, the stock continued to rise in 35 of 50 cases over the following month. The odds of a continued upward trend are 70%.
The 10-day moving average for MSGS crossed bullishly above the 50-day moving average on September 25, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 9 of 13 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 69%.
Following a +3.44% 3-day Advance, the price is estimated to grow further. Considering data from situations where MSGS advanced for three days, in 185 of 295 cases, the price rose further within the following month. The odds of a continued upward trend are 63%.
The Aroon Indicator entered an Uptrend today. In 168 of 242 cases where MSGS Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 69%.
The 10-day RSI Indicator for MSGS moved out of overbought territory on September 29, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 47 similar instances where the indicator moved out of overbought territory. In 27 of the 47 cases, the stock moved lower in the following days. This puts the odds of a move lower at 57%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 30 of 62 cases where MSGS's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 48%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where MSGS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 47%.
MSGS broke above its upper Bollinger Band on September 28, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron Profit vs. Risk Rating rating for this company is 5 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 76, placing this stock better than average.
The Tickeron PE Growth Rating for this company is 36 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 40 (best 1 - 100 worst), indicating steady price growth. MSGS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 94 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 99 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (-20.819) is normal, around the industry mean (18.508). MSGS's P/E Ratio (1301.062) is considerably higher than the industry average of (97.633). Projected Growth (PEG Ratio) (6.550) is also within normal values, averaging (3.885). Dividend Yield (0.000) settles around the average of (0.005) among similar stocks. MSGS's P/S Ratio (8.278) is slightly higher than the industry average of (2.913).